
Kymera Therapeutics KYMR
$ 132.5
6.1%
Kymera Therapeutics PEG Ratio | KYMR
Annual PEG Ratio Kymera Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.16 | - | - | - | - | -0.532 | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.16 | -0.532 | 0.814 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Summit Therapeutics
SMMT
|
0.911 | $ 16.34 | 15.15 % | $ 12.2 B | ||
|
Cabaletta Bio
CABA
|
-0.01 | $ 1.3 | 1.17 % | $ 131 M | ||
|
Syndax Pharmaceuticals
SNDX
|
0.084 | $ 9.53 | 1.39 % | $ 826 M | ||
|
Sanofi
SNY
|
15.5 | $ 47.06 | 0.32 % | $ 57.4 B | ||
|
Forma Therapeutics Holdings
FMTX
|
0.233 | - | - | $ 958 M | ||
|
Blueprint Medicines Corporation
BPMC
|
-120 | - | - | $ 8.14 B | ||
|
Horizon Therapeutics Public Limited Company
HZNP
|
-0.759 | - | - | $ 26.6 B | ||
|
Sarepta Therapeutics
SRPT
|
0.0184 | $ 17.8 | 0.68 % | $ 1.78 B | ||
|
Paratek Pharmaceuticals
PRTK
|
-0.0845 | - | - | $ 121 M | ||
|
China SXT Pharmaceuticals
SXTC
|
-0.000148 | $ 2.84 | -3.07 % | $ 1.93 M | ||
|
Takeda Pharmaceutical Company Limited
TAK
|
0.0268 | $ 21.02 | -0.92 % | $ 33.2 B | ||
|
Tarsus Pharmaceuticals
TARS
|
-0.851 | $ 68.11 | 0.87 % | $ 2.85 B | ||
|
ASLAN Pharmaceuticals Limited
ASLN
|
-0.0728 | - | -14.27 % | $ 1.7 M | ||
|
Bio-Techne Corporation
TECH
|
9.26 | $ 72.78 | 0.17 % | $ 11.4 B | ||
|
Teva Pharmaceutical Industries Limited
TEVA
|
-0.369 | $ 42.32 | 1.33 % | $ 48.5 B | ||
|
RedHill Biopharma Ltd.
RDHL
|
0.312 | $ 0.43 | 0.45 % | $ 5.3 B | ||
|
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | ||
|
Unity Biotechnology
UBX
|
-0.00894 | - | -33.41 % | $ 3.37 M | ||
|
iTeos Therapeutics
ITOS
|
-0.295 | - | - | $ 411 M | ||
|
Shattuck Labs
STTK
|
-0.835 | $ 4.59 | 2.78 % | $ 319 M | ||
|
Seelos Therapeutics
SEEL
|
-0.000255 | - | -47.76 % | $ 6.27 M | ||
|
Evogene Ltd.
EVGN
|
-0.00649 | $ 0.28 | -16.14 % | $ 2.2 M | ||
|
Advaxis
ADXS
|
-0.00008 | - | -9.65 % | $ 45.9 M | ||
|
Protara Therapeutics
TARA
|
0.264 | $ 2.33 | 9.15 % | $ 99.8 M | ||
|
Trevi Therapeutics
TRVI
|
1.94 | $ 14.33 | 11.87 % | $ 1.93 B | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
-0.00342 | $ 4.63 | 21.05 % | $ 20 M | ||
|
Fennec Pharmaceuticals
FENC
|
0.000178 | $ 9.79 | 4.26 % | $ 280 M | ||
|
Kiromic BioPharma
KRBP
|
-0.00492 | - | 6.61 % | $ 3.08 M | ||
|
CNS Pharmaceuticals
CNSP
|
-0.000003 | $ 3.92 | -2.24 % | $ 1.74 M | ||
|
Calithera Biosciences
CALA
|
-0.00162 | - | -10.95 % | $ 876 K | ||
|
United Therapeutics Corporation
UTHR
|
0.805 | $ 562.14 | -0.63 % | $ 24.9 B | ||
|
Vericel Corporation
VCEL
|
-0.889 | $ 54.56 | 5.36 % | $ 2.75 B | ||
|
Veracyte
VCYT
|
1.03 | $ 24.1 | 0.42 % | $ 1.89 B | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
Fulcrum Therapeutics
FULC
|
-0.000402 | $ 3.72 | 0.95 % | $ 236 M | ||
|
Molecular Templates
MTEM
|
-0.00416 | - | -23.43 % | $ 495 K | ||
|
Vanda Pharmaceuticals
VNDA
|
-0.0515 | $ 3.82 | 6.27 % | $ 225 M | ||
|
Verrica Pharmaceuticals
VRCA
|
-0.0249 | $ 3.22 | 4.21 % | $ 34.3 M | ||
|
Viridian Therapeutics
VRDN
|
0.582 | $ 28.47 | -0.28 % | $ 2.9 B | ||
|
BioXcel Therapeutics
BTAI
|
-0.000761 | $ 0.07 | 9.81 % | $ 855 K | ||
|
VistaGen Therapeutics
VTGN
|
-0.0036 | $ 0.17 | 3.45 % | $ 6.47 M | ||
|
Voyager Therapeutics
VYGR
|
0.0127 | $ 1.86 | 8.14 % | $ 109 M | ||
|
CohBar
CWBR
|
-0.000901 | - | -15.44 % | $ 2.2 M | ||
|
NeuBase Therapeutics
NBSE
|
0.00351 | - | -1.56 % | $ 12.3 M | ||
|
Gossamer Bio
GOSS
|
-0.103 | $ 9.77 | 3.72 % | $ 2.23 B | ||
|
Deciphera Pharmaceuticals
DCPH
|
-1.67 | - | - | $ 2.18 B | ||
|
GeoVax Labs
GOVX
|
-0.000282 | $ 0.16 | -5.0 % | $ 153 K | ||
|
Arena Pharmaceuticals
ARNA
|
-0.000409 | - | -6.81 % | $ 3.04 B | ||
|
Scopus BioPharma
SCPS
|
0.036 | - | -48.37 % | $ 3.71 M | ||
|
Annovis Bio
ANVS
|
-0.0518 | $ 0.82 | 23.72 % | $ 16.9 M |